OBJECTIVE AND DESIGN: Chemotaxis of neutrophils from blood to the inflammation process plays an important role in development of periodontal inflammation. The novel chemokine GROalpha, also named CXCL1, is a strong chemoattractant for neutrophils. Data on production and regulation of GROalpha by oral fibroblasts have not previously been presented. MATERIALS AND METHODS: GROalpha mRNA and protein levels were determined in human periodontal ligament cells and mouse gingival fibroblasts by quantitative real-time PCR and ELISA. RESULTS: We disclose that both human periodontal ligament cells and mouse gingival fibroblasts produce GROalpha in response to LPS stimulation. Stimulation with LPS for 24 h increased both mRNA for GROalpha and GROalpha protein. The steroid hormone estrogen had no effect on LPS-induced GROalpha mRNA expression. Treatment with the glucocorticoid dexamethasone attenuated LPS-induced GROalpha production, and the NF-kappaB blocker MG 132 fully prevented LPS-induced GROalpha. CONCLUSIONS: Oral fibroblasts respond to LPS stimulation by increasing GROalpha production via the transcription factor NF-kappaB, suggesting that this mechanism may be involved in development of periodontal inflammation.
OBJECTIVE AND DESIGN: Chemotaxis of neutrophils from blood to the inflammation process plays an important role in development of periodontal inflammation. The novel chemokine GROalpha, also named CXCL1, is a strong chemoattractant for neutrophils. Data on production and regulation of GROalpha by oral fibroblasts have not previously been presented. MATERIALS AND METHODS:GROalpha mRNA and protein levels were determined in human periodontal ligament cells and mouse gingival fibroblasts by quantitative real-time PCR and ELISA. RESULTS: We disclose that both human periodontal ligament cells and mouse gingival fibroblasts produce GROalpha in response to LPS stimulation. Stimulation with LPS for 24 h increased both mRNA for GROalpha and GROalpha protein. The steroid hormone estrogen had no effect on LPS-induced GROalpha mRNA expression. Treatment with the glucocorticoid dexamethasone attenuated LPS-induced GROalpha production, and the NF-kappaB blocker MG 132 fully prevented LPS-induced GROalpha. CONCLUSIONS: Oral fibroblasts respond to LPS stimulation by increasing GROalpha production via the transcription factor NF-kappaB, suggesting that this mechanism may be involved in development of periodontal inflammation.
Authors: Denis F Kinane; Donald R Demuth; Sven-Ulrik Gorr; George N Hajishengallis; Michael H Martin Journal: Periodontol 2000 Date: 2007 Impact factor: 7.589
Authors: S Nilsson; S Mäkelä; E Treuter; M Tujague; J Thomsen; G Andersson; E Enmark; K Pettersson; M Warner; J A Gustafsson Journal: Physiol Rev Date: 2001-10 Impact factor: 37.312
Authors: Unni M Breland; Bente Halvorsen; Johanna Hol; Erik Øie; Gabrielle Paulsson-Berne; Arne Yndestad; Camilla Smith; Kari Otterdal; Ulf Hedin; Torgun Waehre; Wiggo J Sandberg; Stig S Frøland; Guttorm Haraldsen; Lars Gullestad; Jan K Damås; Gøran K Hansson; Pål Aukrust Journal: Arterioscler Thromb Vasc Biol Date: 2008-02-14 Impact factor: 8.311
Authors: P Tekamp-Olson; C Gallegos; D Bauer; J McClain; B Sherry; M Fabre; S van Deventer; A Cerami Journal: J Exp Med Date: 1990-09-01 Impact factor: 14.307
Authors: C J Doyle; T R Fitzsimmons; C Marchant; A A S S K Dharmapatni; R Hirsch; P M Bartold Journal: Clin Oral Investig Date: 2014-05-08 Impact factor: 3.573
Authors: Daniel Svensson; Alexandra Aidoukovitch; Emma Anders; Daniel Jönsson; Daniel Nebel; Bengt-Olof Nilsson Journal: Inflamm Res Date: 2017-06-08 Impact factor: 4.575